1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for TEM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2025. Start Trial.
Date Value
September 29, 2026 5.10%
September 28, 2026 8.41%
September 25, 2026 9.93%
September 24, 2026 3.80%
September 23, 2026 -8.96%
September 22, 2026 -10.11%
September 21, 2026 -11.57%
September 18, 2026 -10.60%
September 17, 2026 -7.04%
September 16, 2026 -19.61%
September 15, 2026 -19.12%
September 14, 2026 -27.98%
September 11, 2026 -33.53%
September 10, 2026 -24.85%
September 09, 2026 -24.36%
September 08, 2026 -19.86%
September 04, 2026 -17.28%
September 03, 2026 -15.24%
September 02, 2026 -20.93%
September 01, 2026 -17.91%
August 31, 2026 -16.89%
August 28, 2026 -13.06%
August 27, 2026 -3.47%
August 26, 2026 -10.25%
August 25, 2026 -9.45%
Date Value
August 24, 2026 -17.82%
August 21, 2026 -5.24%
August 20, 2026 -9.05%
August 19, 2026 -16.19%
August 18, 2026 -37.08%
August 17, 2026 -30.01%
August 14, 2026 -27.22%
August 13, 2026 -22.03%
August 12, 2026 -17.68%
August 11, 2026 -8.43%
August 10, 2026 -9.54%
August 07, 2026 -11.39%
August 06, 2026 -16.95%
August 05, 2026 -19.12%
August 04, 2026 -18.20%
August 03, 2026 -16.10%
July 31, 2026 -22.48%
July 30, 2026 -23.39%
July 29, 2026 -28.72%
July 28, 2026 -30.81%
July 27, 2026 -33.46%
July 24, 2026 -32.60%
July 23, 2026 -29.06%
July 22, 2026 -23.12%
July 21, 2026 -15.57%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Personalis, Inc. 157.5%
10X Genomics, Inc. 694.0%
Twist Bioscience Corp. 589.4%
Moderna, Inc. 703.2%
IQVIA Holdings, Inc. 48.84%